Measles Vaccine Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)
- Report Code : 99S2683067
- Published On: Sep, 2021
- Category : Healthcare & Pharma
- Pages : 50
-
According to Study, the Global Measles Vaccine Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Measles Vaccine market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
Key Product Type
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Market by Application
Children
Adults
Main Aspects covered in the Report
Overview of the Measles Vaccine market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
-
With tables and figures helping analyze worldwide Measles Vaccine market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Industrial Chain Overview1.1 Measles Vaccine Industry
1.1.1 Overview
Figure Measles Vaccine Picture List
1.1.2 Characteristics of Measles Vaccine1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview1.3 Product List By Type
1.3.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.3.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)1.4 End-Use List
1.4.1 Demand in Children
1.4.2 Demand in Adults1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 20213.2 Manufacturers List
3.2.1 GSK Overview
Table GSK Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of GSK (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Sanofi-Pasteur Overview
Table Sanofi-Pasteur Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Sanofi-Pasteur (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Merck Overview
Table Merck Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Novartis Overview
Table Novartis Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Pfizer Overview
Table Pfizer Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Serum Institute of India Overview
Table Serum Institute of India Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Serum Institute of India (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 China National Biotech Group Overview
Table China National Biotech Group Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of China National Biotech Group (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Bavarian Nordic Overview
Table Bavarian Nordic Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Bavarian Nordic (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Emergent Biosolutions Overview
Table Emergent Biosolutions Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Emergent Biosolutions (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Medimmune Overview
Table Medimmune Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Medimmune (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Johnson & Johnson Overview
Table Johnson & Johnson Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 CSL Limited Overview
Table CSL Limited Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Measles Vaccine Business Operation of CSL Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
4 Market Competition Pattern4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume5.2 Segment Subdivision by Product Type
5.2.1 Market in Mumps Measles Rubella Vaccine, Live (MMR-II)
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Mumps Measles Rubella Vaccine, Live (MMR-II), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Mumps Measles Rubella Vaccine, Live (MMR-II), 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Mumps Measles Rubella and Varicella Virus Vaccine (Proquad), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Mumps Measles Rubella and Varicella Virus Vaccine (Proquad), 2017-2021, in Volume
5.2.2.2 Situation & Development
6 End-Use Segment6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume6.2 Segment Subdivision
6.2.1 Market in Children
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Children, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Children, 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Adults
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Adults, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Adults, 2017-2021, in Volume
6.2.2.2 Situation & Development
7 Market Forecast & Trend7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio8.2 Channel Segment
9 Market Drivers & Investment Environment9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Measles Vaccine Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion
-
The Measles Vaccine Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Depending upon the type of applications, the Measles Vaccine Market has been segmented into
In 2023, the Measles Vaccine Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Measles Vaccine Market as well as its distribution among its players
The Measles Vaccine Market is expected to reach a considerable market valuation.
